Cargando…

Adrenomedullin Expression Is Associated With the Severity and Poor Prognosis of Interstitial Lung Disease in Dermatomyositis Patients

OBJECTIVE: To evaluate adrenomedullin mRNA levels in the peripheral blood mononuclear cells (PBMCs) of patients with dermatomyositis (DM) as well as their correlation with the severity of interstitial lung disease (ILD). METHODS: A total of 41 DM patients and seven immune-mediated necrotizing myopat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Lifang, Zuo, Yu, Chen, Fang, Xu, Yuetong, Zhang, Puli, Yang, Hongxia, Peng, Qinglin, Wang, Guochun, Shu, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200949/ https://www.ncbi.nlm.nih.gov/pubmed/35720354 http://dx.doi.org/10.3389/fimmu.2022.885142

Ejemplares similares

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2022)

Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort
por: Chen, Fang, et al.
Publicado: (2022)

Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome
por: Zuo, Yu, et al.
Publicado: (2022)

HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease
por: Shu, Xiaoming, et al.
Publicado: (2016)

miR-18a-3p and Its Target Protein HuR May Regulate Myogenic Differentiation in Immune-Mediated Necrotizing Myopathy
por: Ye, Lifang, et al.
Publicado: (2022)

Specific Autoantibodies and Clinical Phenotypes Correlate with the Aberrant Expression of Immune-Related MicroRNAs in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2019)

Potential role of autophagy in T-cell survival in polymyositis and dermatomyositis
por: Shu, Xiaoming, et al.
Publicado: (2017)

Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts
por: Ge, Yongpeng, et al.
Publicado: (2017)

Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients
por: Qian, Jinjing, et al.
Publicado: (2023)

Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
por: Geven, Christopher, et al.
Publicado: (2018)

The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients
por: Chen, Xixia, et al.
Publicado: (2022)

Predictors of rapidly progressive interstitial lung disease and prognosis in Chinese patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis
por: Li, Meiqi, et al.
Publicado: (2023)

The molecular mechanism underlying dermatomyositis related interstitial lung disease: evidence from bioinformatic analysis and in vivo validation
por: Zeng, Li, et al.
Publicado: (2023)

Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I
por: Zhang, Lu, et al.
Publicado: (2023)

Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis
por: Li, Wenli, et al.
Publicado: (2016)

Rituximab in the Treatment of Interstitial Lung Diseases Related to Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis: A Systematic Review
por: He, Chenjia, et al.
Publicado: (2022)

Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis
por: Li, Wenli, et al.
Publicado: (2021)

Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
por: Tolppanen, Heli, et al.
Publicado: (2017)

Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis
por: Li, Ting, et al.
Publicado: (2016)

Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease
por: Gui, Xianhua, et al.
Publicado: (2022)

Serum S100A12 levels are correlated with clinical severity in patients with dermatomyositis-associated interstitial lung disease
por: Lou, Yueyan, et al.
Publicado: (2019)

The RIG-I pathway is involved in peripheral T cell lymphopenia in patients with dermatomyositis
por: Zhang, Lu, et al.
Publicado: (2019)

Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis
por: Gan, Yu-Zhou, et al.
Publicado: (2020)

Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis
por: Chen, Cuihong, et al.
Publicado: (2021)

Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis
por: Tanaka, Atsushi, et al.
Publicado: (2015)

Fibrocellular non‐specific interstitial pneumonia with favourable prognosis in clinically amyopathic dermatomyositis
por: Yoshizawa, Takahiro, et al.
Publicado: (2016)

Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity
por: He, Linrong, et al.
Publicado: (2020)

KL-6 as an Immunological Biomarker Predicts the Severity, Progression, Acute Exacerbation, and Poor Outcomes of Interstitial Lung Disease: A Systematic Review and Meta-Analysis
por: Zhang, Tao, et al.
Publicado: (2021)

Research progress on amyopathic dermatomyositis associated with interstitial lung disease
por: Bai, Yu, et al.
Publicado: (2020)

Tozinameran: Dermatomyositis complicated by interstitial lung disease: case report
Publicado: (2022)

The composition of the lung microbiome differs between patients with dermatomyositis and rheumatoid arthritis associated with interstitial lung disease
por: Lou, Yueyan, et al.
Publicado: (2021)

High CD8(+)tumor-infiltrating lymphocytes indicate severe exhaustion and poor prognosis in angioimmunoblastic T-cell lymphoma
por: Zhu, Qiqi, et al.
Publicado: (2023)

A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis
por: Xu, Wenwen, et al.
Publicado: (2021)

Serum levels of interleukins and S100A8/A9 correlate with clinical severity in patients with dermatomyositis-associated interstitial lung disease
por: Lou, Yueyan, et al.
Publicado: (2020)

Systemic immune inflammation index and peripheral blood carbon dioxide concentration at admission predict poor prognosis in patients with severe traumatic brain injury
por: Chen, Li, et al.
Publicado: (2023)

Adrenomedullin Therapy in Moderate to Severe COVID-19
por: Kita, Toshihiro, et al.
Publicado: (2022)

Predictors of Poor Outcome of Anti-MDA5-Associated Rapidly Progressive Interstitial Lung Disease in a Chinese Cohort with Dermatomyositis
por: Li, Yuhui, et al.
Publicado: (2020)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Cytokine profiles of amyopathic dermatomyositis with interstitial lung diseases treated with mycophenolate
por: Hayashi, Masachika, et al.
Publicado: (2017)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
por: Palmucci, Stefano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uou7hgisltaekota0rg1jtorog